Alivus Life Sciences Reports Flat Performance Amidst Notable Profit Growth in August 2025

Aug 01 2025 08:04 PM IST
share
Share Via
Alivus Life Sciences has announced its financial results for the quarter ending June 2025, revealing a flat performance. However, the Profit After Tax for the past six months reached Rs 263.41 crore, reflecting a year-on-year growth of 25.78%, indicating potential positive trends in profitability.
Alivus Life Sciences, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, released on August 1, 2025, indicate a flat financial performance during this period. Notably, the company's score has undergone an adjustment, reflecting a shift from 10 to 4 over the past three months.

Despite the overall performance, there are positive indicators within the financials. The Profit After Tax (PAT) for the latest six months stands at Rs 263.41 crore, showcasing a year-on-year growth of 25.78%. This suggests a favorable near-term trend in profitability, which may be a point of interest for stakeholders observing the company's trajectory.

As Alivus Life Sciences navigates its current financial landscape, the recent evaluation changes highlight the complexities of its performance metrics. Investors and analysts alike will be keen to monitor how these developments unfold in the coming periods.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News